
Published
04 October 2011 | By CoreLab Partners
Dual energy X-ray absorptiometry (DXA) is an efficient, noninvasive, low-radiation dose measurement of bone mineral content (BMC), bone mineral density (BMD), and total body composition (fat and fat-free mass). It's currently the most common imaging tool used to determine BMD for disease processes such as osteoporosis. DXA offers low-radiation dosing (1/10 of the typical chest X-ray), rapid scan time, and ease of use. These distinctive attributes make DXA widely popular in the clinical research arena especially in trials employing bone density as a safety or efficacy endpoint.
As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Fill In Details
By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory
Fields marked * are compulsory